IPHA - Innate Pharma S.A. - American Depositary Shares Summary, Stock Quote and News | Benzinga

Skip to main content

Market Overview

4.016 0.086 (2.19%)

Data as of May 16, 2021

Prev. Close 3.93
Price Open 3.89
Volume 2,478
Day's Range 3.83 - 4.02
52 Wk Range 3.55 - 7.59
50 Day Moving Avg. 4.29
PE Ratio
Shares Outstanding 78.98M
Market Cap 317.19M

Trade IPHA stock for free with recommended broker TD Ameritrade.

Analyst Rating View All Ratings

Earnings Scheduled For May 11, 2021 Benzinga InsightsTue, 11 May 2021 04:13:50 -0400
SVB Leerink Maintains Market Perform on Innate Pharma, Raises Price Target to $7 Benzinga NewsdeskFri, 19 Mar 2021 06:21:11 -0400
Innate Pharma To Test Lacutamab In Relapsed/Refractory Peripheral T-Cell Lymphoma Patients Vandana SinghTue, 09 Feb 2021 08:19:07 -0400
Innate's First NK Cell Engager Selected by Sanofi as Drug Candidate for Development Charles GrossTue, 05 Jan 2021 06:50:14 -0400
SVB Leerink Downgrades Innate Pharma to Market Perform, Lowers Price Target to $5 Benzinga NewsdeskTue, 15 Dec 2020 07:10:26 -0400
HC Wainwright & Co. Maintains Buy on Innate Pharma, Lowers Price Target to $11.5 Benzinga NewsdeskMon, 14 Dec 2020 07:19:21 -0400
72 Biggest Movers From Friday Lisa LevinMon, 14 Dec 2020 05:35:06 -0400
Innate Pharma shares are trading lower after the company announced it will return the US and EU commercialization rights of Lumoxiti to AstraZeneca. Benzinga NewsdeskFri, 11 Dec 2020 14:05:10 -0400
60 Stocks Moving In Friday's Mid-Day Session Lisa LevinFri, 11 Dec 2020 13:08:22 -0400
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street Shanthi RexalineFri, 11 Dec 2020 09:11:34 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Innate Pharma Virtual 2021 Annual General Meeting Globe Newswire4 days ago
Innate Pharma First Quarter 2021 Report Globe Newswire5 days ago
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update Globe NewswireMay 04, 2021
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update Globe NewswireMay 04, 2021
Innate Pharma Files Its 2020 Universal Registration Document (Document D'enregistrement Universel) and 2020 Annual Report on Form 20-F Globe NewswireApr 28, 2021
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 28, 2021 Globe NewswireApr 21, 2021
Number of Shares and Voting Rights of Innate Pharma as of April 1, 2021 Globe NewswireApr 19, 2021
Innate Pharma Reports Full Year 2020 Financial(1) Results and Business Update Globe NewswireMar 18, 2021
Innate Pharma Announces Conference Call and Webcast for Full Year 2020 Financial Results Globe NewswireMar 16, 2021
Number of shares and voting rights of Innate Pharma as of February 1, 2021 Globe NewswireFeb 24, 2021
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Innate Pharma S.A. (IPHYF) CEO Mondher Mahjoubi on Q1 2021 Results - Earnings Call Transcript Seeking Alpha4 days ago
Innate Pharma: Attractive Price, But Comes With Uncertainty Seeking AlphaJan 29, 2021
Innate Pharma files $200M equity shelf Seeking AlphaJan 13, 2021
Sanofi selects Innate's first NK cell engager as drug candidate for development Seeking AlphaJan 05, 2021
Innate Pharma gives back US, EU Lumoxiti rights to AZN Seeking AlphaDec 11, 2020
EMA grants PRIME tag to Innate Pharma's lacutamab for T-cell lymphoma Seeking AlphaNov 13, 2020
Tonix Provides Updates For Fibromyalgia, And Other News: The Good, Bad And Ugly Of Biopharma Seeking AlphaOct 28, 2020
Dosing underway for Innate/AstraZeneca's monalizumab in late-stage head & neck cancer study Seeking AlphaOct 23, 2020
Innate Pharma nabs €6.8M grant for COVID-19 research activities Seeking AlphaAug 11, 2020
Innate Pharma Announces Publication of EXPLORE COVID-–9 Translational Study Findings in Nature GuruFocusJul 29, 2020
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Start Investing

The Best Online Stock Trading Brokers

Best Free Stock Trading Brokers

Best Forex Brokers

Best Futures Brokers

How to Invest in Real Estate

Best Day Trading Courses